2024 Annual Eric Dostie Memorial College Scholarship Recipients
September 24, 2024 13:34 ET
|
FFF Enterprises.com
TEMECULA, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc. announces its 2024 Eric Dostie Memorial College Scholarship...
Hemophilia Patient Receives FDA Approved Gene Therapy Treatment Likely To Eliminate The Need For Preventative Factor Replacement
July 31, 2024 04:00 ET
|
Cure 4 The Kids Foundation
LAS VEGAS, July 31, 2024 (GLOBE NEWSWIRE) -- Cure 4 The Kids Foundation (C4K) announced it has completed Nevada’s first successful infusion of Hemgenix®, a gene therapy option for adult patients...
2023 Annual Eric Dostie Memorial College Scholarship Recipients
November 13, 2023 16:34 ET
|
FFF Enterprises.com
TEMECULA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises Inc. announces its 2023 scholarship recipients. The scholarship program...
Bleeding Disorders Market to Reach $26 Billion, Globally, by 2032 at 6.6% CAGR: Allied Market Research
June 22, 2023 08:40 ET
|
Allied Market Research
Portland, OR, June 22, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Bleeding disorders Market by Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease and...
Bleeding Disorders Treatment Market will reach to USD 31.44 billion by 2029, at a CAGR of 8.9%% by 2029 : GreyViews
December 07, 2022 09:00 ET
|
GreyViews
Pune India, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
2020 Annual Eric Dostie Memorial College Scholarship Winners
September 28, 2020 09:00 ET
|
FFF Enterprises.com
Temecula, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc., announces its 2020 scholarship recipients. The scholarship program...